NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
Quarterly report [Sections 13 or 15(d)]
Current report
Definitive proxy statements
View and filter by group or type
